BrainStorm CEO Lands 1.8 Million RSUs at Zero Cost as Executives Bulk Up Holdings Amid Quiet Insider Buying Surge
BrainStorm insiders buy 1.8 M RSUs at no cost, boosting CEO holdings by 10 %—a bullish sign ahead of Phase 3b trials and possible funding boosts.
- BrainStorm Cell Therapeutics Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read